The Scleroderma Book - Mayes, Maureen D.
34,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
17 °P sammeln
  • Gebundenes Buch

One of the nation's leading authorities on scleroderma--an auto-immune disease in the Lupus family--provides the first comprehensive guide to the disease written especially for patients and their families.
This book is for patients and loved ones who would like to know more about the baffling disease called scleroderma. It is written in an easy to understand, almost conversational, format. The goal is to demystify scleroderma. The book discusses tests that are used to make the diagnosis and to monitor the disease, current treatments as well as potential new therapies, and theories about the…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
One of the nation's leading authorities on scleroderma--an auto-immune disease in the Lupus family--provides the first comprehensive guide to the disease written especially for patients and their families.
This book is for patients and loved ones who would like to know more about the baffling disease called scleroderma. It is written in an easy to understand, almost conversational, format. The goal is to demystify scleroderma. The book discusses tests that are used to make the diagnosis and to monitor the disease, current treatments as well as potential new therapies, and theories about the cause of scleroderma including the role of the immune system and the role of genetics.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Maureen Mayes, M.D. is Professor of Medicine at the University of Texas Houston Medical School, where she directs the Scleroderma Clinic. Dr Mayes has been active in scleroderma research, clinical trials and patient care for over 20 years. She is the author of multiple papers and book chapters on the subject and is a past president and director of the National Board of Directors for the United Scleroderma Foundation, and serves on its Medical Advisory Board. Her professional career has been devoted to the study and treatment of scleroderma. She is the principle investigator for the National Institutes of Health Scleroderma Registry, which seeks to identify common factors amongst patients that could explain their susceptibility to develop this disease. This book represents many years of experience in explaining this puzzling disease to patients and family members.